140 related articles for article (PubMed ID: 2505337)
1. Molecular dosimetry of hepatic aflatoxin B1-DNA adducts: linear correlation with hepatic cancer risk.
Bechtel DH
Regul Toxicol Pharmacol; 1989 Aug; 10(1):74-81. PubMed ID: 2505337
[TBL] [Abstract][Full Text] [Related]
2. Quantitative carcinogenesis and dosimetry in rainbow trout for aflatoxin B1 and aflatoxicol, two aflatoxins that form the same DNA adduct.
Bailey GS; Loveland PM; Pereira C; Pierce D; Hendricks JD; Groopman JD
Mutat Res; 1994 Aug; 313(1):25-38. PubMed ID: 7519308
[TBL] [Abstract][Full Text] [Related]
3. Comparative effect of dietary butylated hydroxyanisole and beta-naphthoflavone on aflatoxin B1 metabolism, DNA adduct formation, and carcinogenesis in rainbow trout.
Goeger DE; Shelton DW; Hendricks JD; Pereira C; Bailey GS
Carcinogenesis; 1988 Oct; 9(10):1793-800. PubMed ID: 3139317
[TBL] [Abstract][Full Text] [Related]
4. Molecular dosimetry in fish: quantitative target organ DNA adduction and hepatocarcinogenicity for four aflatoxins by two exposure routes in rainbow trout.
Bailey GS; Dashwood R; Loveland PM; Pereira C; Hendricks JD
Mutat Res; 1998 Mar; 399(2):233-44. PubMed ID: 9672662
[TBL] [Abstract][Full Text] [Related]
5. Aflatoxin B1 carcinogenesis and its relation to DNA adduct formation and adduct persistence in sensitive and resistant salmonid fish.
Bailey GS; Williams DE; Wilcox JS; Loveland PM; Coulombe RA; Hendricks JD
Carcinogenesis; 1988 Nov; 9(11):1919-26. PubMed ID: 3141073
[TBL] [Abstract][Full Text] [Related]
6. A review of the dose-response induction of DNA adducts by aflatoxin B1 and its implications to quantitative cancer-risk assessment.
Choy WN
Mutat Res; 1993 Mar; 296(3):181-98. PubMed ID: 7680102
[TBL] [Abstract][Full Text] [Related]
7. The use of monoclonal antibody affinity columns for assessing DNA damage and repair following exposure to aflatoxin B1.
Groopman JD; Kensler TW
Pharmacol Ther; 1987; 34(2):321-34. PubMed ID: 3120202
[TBL] [Abstract][Full Text] [Related]
8. Linear dose-response relationship for DNA adducts in rat liver from chronic exposure to aflatoxin B1.
Buss P; Caviezel M; Lutz WK
Carcinogenesis; 1990 Dec; 11(12):2133-5. PubMed ID: 2124951
[TBL] [Abstract][Full Text] [Related]
9. Alteration of the aflatoxin cyclopentenone ring to a delta-lactone reduces intercalation with DNA and decreases formation of guanine N7 adducts by aflatoxin epoxides.
Raney KD; Gopalakrishnan S; Byrd S; Stone MP; Harris TM
Chem Res Toxicol; 1990; 3(3):254-61. PubMed ID: 2131838
[TBL] [Abstract][Full Text] [Related]
10. Do aflatoxin-DNA adduct measurements in humans provide accurate data for cancer risk assessment?
Groopman JD
IARC Sci Publ; 1988; (89):55-62. PubMed ID: 3143672
[TBL] [Abstract][Full Text] [Related]
11. Aflatoxin B1 formamidopyrimidine adducts in human hepatocarcinogenesis: a preliminary report.
Lee HS; Sarosi I; Vyas GN
Gastroenterology; 1989 Nov; 97(5):1281-7. PubMed ID: 2551766
[TBL] [Abstract][Full Text] [Related]
12. [The association between aflatoxin exposure and primary hepatocellular carcinoma risks: a case-control study in Chongqing].
Zheng CF; Zeng H; Wang J; Lin H; Feng XB; Chen JA; Qiu ZQ; Luo JH; Xu AW; Wang LQ; Tan Y; Chen S; Jiang P; Shu WQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):539-545. PubMed ID: 28592100
[No Abstract] [Full Text] [Related]
13. The formation of AFB(1)-macromolecular adducts in rats and humans at dietary levels of exposure.
Cupid BC; Lightfoot TJ; Russell D; Gant SJ; Turner PC; Dingley KH; Curtis KD; Leveson SH; Turteltaub KW; Garner RC
Food Chem Toxicol; 2004 Apr; 42(4):559-69. PubMed ID: 15019179
[TBL] [Abstract][Full Text] [Related]
14. Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China.
Groopman JD; Zhu JQ; Donahue PR; Pikul A; Zhang LS; Chen JS; Wogan GN
Cancer Res; 1992 Jan; 52(1):45-52. PubMed ID: 1727385
[TBL] [Abstract][Full Text] [Related]
15. Aflatoxin B1-2,3-oxide as a probable intermediate in the covalent binding of aflatoxins B1 and B2 to rat liver DNA and ribosomal RNA in vivo.
Swenson DH; Lin JK; Miller EC; Miller JA
Cancer Res; 1977 Jan; 37(1):172-81. PubMed ID: 187331
[TBL] [Abstract][Full Text] [Related]
16. Linear dose-response curve for the hepatic macromolecular binding of aflatoxin B1 in rats at very low exposures.
Appleton BS; Goetchius MP; Campbell TC
Cancer Res; 1982 Sep; 42(9):3659-62. PubMed ID: 6179606
[TBL] [Abstract][Full Text] [Related]
17. Quantitative inter-relationships between aflatoxin B1 carcinogen dose, indole-3-carbinol anti-carcinogen dose, target organ DNA adduction and final tumor response.
Dashwood RH; Arbogast DN; Fong AT; Pereira C; Hendricks JD; Bailey GS
Carcinogenesis; 1989 Jan; 10(1):175-81. PubMed ID: 2491968
[TBL] [Abstract][Full Text] [Related]
18. Analysis of ras gene mutations in rainbow trout liver tumors initiated by aflatoxin B1.
Chang YJ; Mathews C; Mangold K; Marien K; Hendricks J; Bailey G
Mol Carcinog; 1991; 4(2):112-9. PubMed ID: 1645972
[TBL] [Abstract][Full Text] [Related]
19. Aflatoxins as a cause of hepatocellular carcinoma.
Kew MC
J Gastrointestin Liver Dis; 2013 Sep; 22(3):305-10. PubMed ID: 24078988
[TBL] [Abstract][Full Text] [Related]
20. Preferential attack of mitochondrial DNA by aflatoxin B1 during hepatocarcinogenesis.
Niranjan BG; Bhat NK; Avadhani NG
Science; 1982 Jan; 215(4528):73-5. PubMed ID: 6797067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
